학술논문

Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma.
Document Type
journal article
Source
BMC Pulmonary Medicine; 5/2/2022, Vol. 22 Issue 1, p1-6, 6p
Subject
PROGNOSIS
PLEURAL effusions
LYMPHOCYTES
MESOTHELIOMA
SURVIVAL rate
TUMORS
Language
ISSN
14712466
Abstract
Copyright of BMC Pulmonary Medicine is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)